The Misleading "pooled Effect Estimate" of Crude Data from Observational Studies at Critical Risk of Bias: The Case of Tocilizumab in Coronavirus Disease 2019 (COVID-19)

Tleyjeh, I. M. (2021, June 15). The Misleading “pooled Effect Estimate” of Crude Data from Observational Studies at Critical Risk of Bias: The Case of Tocilizumab in Coronavirus Disease 2019 (COVID-19). Clinical Infectious Diseases. Oxford University Press. https://doi.org/10.1093/cid/ciaa1735